Histopathological study of Non-neoplastic
& Neoplastic ovarian lesions in a tertiary care hospital in Gujarat, India
Maru A.M1,Menapara C.B.2
1Dr. Alpesh M Maru, Assistant
Professors, 2Dr. Chiragkumar B. Menapara, Assistant Professors, both
authors are affiliated with Department of Pathology, GMERS Medical College&
Hospital, Junagadh, Gujarat, India.
Corresponding Author: Dr. Chiragkumar B. Menapara,
Assistant Professors; Department of Pathology, GMERS Medical College &
Hospital, Junagadh, Gujarat, India. E-mail: drmaru28@gmail.com
Abstract
Aims
& Objectives:(1) To know about
various histopathological types of ovarian lesions presented and diagnosed at
our institute. (2) To study the incidence of ovarian lesions with respect to
patient’s age. (3) To study the frequency of ovarian lesions in terms of
non-neoplastic or neoplastic, benign or malignant, unilateral or bilateral,
etc. Materials & Methods: The present study was performed at the
Department of Pathology, GMERS Medical College & Hospital-Junagadh
(Gujarat, India) from January 2015 to December 2018 and includes 100 cases of
ovarian lesions diagnosed on both clinical & histopathological basis. We
have received ovarian specimens and performed routine grossing and H& E
staining procedure. We have included parameters like Age wise incidence, Nature
of Lesion, Frequency & Laterality in this present study. Results: Out
of100 cases, 89% are unilateral and 11% are bilateral. 52% lesions are Benign
Neoplasms, 44% lesions are Non-neoplastic Cysts and 4% lesions are Borderline
& Malignant Neoplasms. Majority of cases (58%) belong to age group of 20-39
years. Among Non-neoplastic Lesions, Follicular Cyst is common & frequently
bilateral while among Benign Neoplasms, Serous Cystadenoma is common &
frequently bilateral.Conclusion: Ovarian Lesions both non-neoplastic and
neoplastic include a variety of morphological features and show a particular
age wise incidence. Role of histopathological evaluation remains always
important in both diagnosis & management of such cases, particularly in
cases of Malignant Lesions in order to save the patient’s life.
Key words:Non-neoplastic, Benign, Borderline, Malignant, Follicular
Cyst, Serous Cystadenoma
Introduction
Ovarian
enlargements (lesions), cystic or solid, may occur at any age [1]. These enlargements
may be Non-neoplastic or Neoplastic in nature. Non-Neoplastic Enlargements include Simple Follicular Cysts, Corpus
Leuteal Cysts, Chocolate Cysts due to Endometriosis, Twisted Hemorrhagic Cysts,
Polycystic Ovarian Disease (PCOD), Various Inflammatory Lesions, etc. To define a functional non-neoplastic cyst,
its size or diameter must be at least 3 cm, but not more than 7 cm [1]. Non-Neoplastic Enlargements develop
almost exclusively during the childbearing years. They may be asymptomatic or
produce local discomfort, menstrual disturbances, infertility, or in rare cases
cause acute symptoms due to complications like haemorrhage, rupture or torsion
[1].
Neoplastic
disorders or lesionsof Ovary can arise from (1) Mullerian epithelium, (2) Germ
cells or (3) Sex cord Stromal cells [2]. Classification of Ovarian Neoplasms
given by WHO is completely based upon the tissue of origin. It includes a
variety of entities like Surface Epithelial Tumors, Sex cord Stromal Tumors,
Pure or Mixed Germ Cell Tumors, Gonadoblastoma, Soft Tissue Tumors, Metastatic
Tumors, Unclassified Tumors, etc. Surface Epithelial Tumors are further
categorized into benign, borderline and malignant [1,3]. Ovarian neoplasms behave
in diverse way and generally escape the detection until they attain a larger
size. This is primarily due to the reason that either the symptoms are vague or
most of these are asymptomatic therefore they manifest over a time period due to no definite screening
program. Therefore, diagnosis of various histological patterns of ovarian
tumors is very important in the treatment and prognosis. [2]
Aims & Objectives
To
know about various histopathological types of ovarian lesions presented and
diagnosed at our institute
To
study the incidence ofovarian lesions with respect to patient’s age
To
study the frequency of ovarian lesions in terms of non-neoplastic or
neoplastic, benign or malignant, unilateral or bilateral, etc.
Material & Method
The
present retrospective studywas
performed at the Department of Pathology, GMERS Medical College& Hospital-Junagadh (Gujarat, India) from January
2015 to December 2018 for a period of 4 years. It includes a total number of 100
random cases of ovarian lesions
diagnosed initially on the basis of clinical findings and finally on the basis
of histopathological examination.
Nature of Specimens
Solitary
Salpingooophorectomy specimens, Unilateral or Bilateral
Hysterectomy
with Unilateral Salpingooophorectomy specimens
Hysterectomy
with Bilateral Salpingooophorectomy specimens
Inclusion
Criteria:All ovarian biopsy with abnormal
findings on sonography.
Exclusion Criteria:
1.
History of previous chemotherapy or radiotherapy
2.
Age below 20 years.
These
specimens have been received from Gynecology Department with sufficient &
relevant clinical and radiological findings in a specific Performa for further
Histopathological Evaluation at our Department. After a number of necessary
technical steps like Fixation in 10% Formalin, Gross Examination, Surgical
Dissection, Tissue Processing, Paraffin Embedding, Microtomy, staining with
routine H-E method & Mounting of Slides using DPX, Microscopic Slides have
been made available for further evaluation & final diagnosis.All slides have
been viewed by at least two Pathologists before final reporting and all lesions
have beenclassified using WHO guidelines. Data are plotted and statistical
analysis was carried out with the help of SPSS (Statistical packages for social
science) and by using X2- chi square test. P value less than 0.001
is significant.
Results
A
total of 100 specimens of ovarian lesions have been received for
histopathological evaluation at our department & out of them, 89 lesions are
unilateral and 11 lesions are bilateral. 52% lesions are Benign Neoplasms, 44%
lesions are Non-neoplastic Cysts and 4% lesions are Borderline & Malignant
Neoplasms. Histopathological Categorization of Various Ovarian Lesions is given
below in Table no.1 and their Age-wise incidence is given below in Table no.2.
Table No-1: Histopathological
Categorization of various Ovarian Lesions
Sr.No. |
HistopathologicalDiagnosis or Category |
Number of Cases and % |
Unilateral Cases |
Bilateral Cases |
Non-neoplastic
lesions |
||||
1 |
Follicular Cysts |
20 |
17 |
03 |
2 |
Corpus Leuteal Cysts |
14 |
11 |
03 |
3 |
Hemorrhagic Twisted Ovarian Cysts |
06 |
06 |
-- |
4 |
Endometriosis & Chocolate Cysts |
04 |
04 |
-- |
Benign
neoplasms |
||||
5 |
Serous Cystadenoma |
28 |
24 |
04 |
6 |
Mature Cystic Teratoma |
13 |
13 |
-- |
7 |
Mucinous Cystadenoma |
06 |
05 |
01 |
8 |
Serous Cystadenofibroma |
03 |
03 |
-- |
9 |
Mature Teratoma with Struma Ovarii |
01 |
01 |
-- |
10 |
Brenner’s Tumor (Benign) |
01 |
01 |
-- |
Borderline
&malignant neoplasms |
||||
11 |
Borderline Mucinous Tumor |
01 |
01 |
-- |
12 |
Papillary Serous Cystadenocarcinoma |
01 |
01 |
-- |
13 |
Granulosa Cell Tumor of Adult Type |
01 |
01 |
-- |
14 |
Dysgerminoma |
01 |
01 |
-- |
|
Total |
100 |
89 |
11 |
TableNo.-2: Age-wise Incidence of
various Ovarian Lesions
Sr. No. |
Histopathological Diagnosis or Category |
20-39 years |
40-59 years |
60 years & above |
Total |
1 |
Follicular Cysts |
14 |
06 |
-- |
20 |
2 |
Corpus Leuteal Cysts |
08 |
06 |
-- |
14 |
3 |
Hemorrhagic Twisted Ovarian Cysts |
06 |
-- |
-- |
06 |
4 |
Endometriosis & Chocolate Cysts |
-- |
03 |
01 |
04 |
5 |
Serous Cystadenoma |
15 |
08 |
05 |
28 |
6 |
Mature Cystic Teratoma |
07 |
05 |
01 |
13 |
7 |
Mucinous Cystadenoma |
04 |
01 |
01 |
06 |
8 |
Serous Cystadenofibroma |
03 |
-- |
-- |
03 |
9 |
Mature Teratoma with Struma Ovarii |
-- |
01 |
-- |
01 |
10 |
Brenner’s Tumor (Benign) |
-- |
01 |
-- |
01 |
11 |
Borderline Mucinous Tumor |
-- |
01 |
-- |
01 |
12 |
Papillary Serous Cystadenocarcinoma |
-- |
-- |
01 |
01 |
13 |
Granulosa Cell Tumor of Adult Type |
-- |
01 |
-- |
01 |
14 |
Dysgerminoma |
01 |
-- |
-- |
01 |
|
Total |
58 |
32 |
10 |
100 |
As
mentioned above in both tables, Simple Follicular Cysts are the commonest among
all Non-neoplastic Cystic Lesions and often bilateral. Non-neoplastic Cysts are
seen in comparatively younger females belonging to age group of 20-39 years and
quite rare after menopause because of complete cessation of normal &
regular menstrual cycles.
Among
various benign neoplasms, Serous Cystadenoma is the commonest & often
bilateral. Next common benign neoplasm is Mature Cystic Teratoma or Dermoid
Cyst of Ovary that is often unilateral. Both of these benign tumors can occur
at any age but commonly seen before 40 years of age during reproductive period
of life. Other benign neoplasms like Mucinous Cystadenoma and Serous
Cystadenofibroma are also seen in younger females. Brenner’s Tumor is an
uncommon subtype of the surface epithelial tumors of ovary and Majority of the
cases are benign in nature. This tumor is particularly seen between 40-60 years
of age.
Our
present study includes total 4 cases of Borderline & Malignant Neoplasms
namely Serous Cystadenocarcinoma (65 years old), Granulosa Cell Tumor of Adult
Type (45 years old), Dysgerminoma (32 years old) and Borderline Mucinous Tumor
(48 years old).
Fig
1a shows Struma Ovarii with extensive
normal looking thyroid tissue. 1b shows Benign
Brenner’s
Tumor with characteristic transitional or urothelial component giving a
biphasic appearance.
Fig
2a shows Borderline Mucinous Tumor of
ovary, a tumor with nuclear atypia and having low
malignant
potential (in-between benign & malignant). 2b shows Papillary Serous
Cystadenocarcinoma
of
ovary with features of anaplasia and aggressiveness.
Fig
no. 3a shows Granulosa Cell Tumor of Adult
Type with characteristic Coffee-bean Nuclei.
3b
shows Dysgerminoma of Ovary looking more or less similar to the classical
seminoma
of the testis having clear looking cells.
Figure
no. 1a, 1b, 2a & 2b shows microscopic photographic images of various
lesions under low power magnification (H & E stain, 100x) while figure no.
3a & 3b shows images under high power magnification (H & E stain,
400x).
Discussion
Our
present study includes total 100 cases of Ovarian Lesions diagnosed finally on
histopathological basis. Out of them, 89% cases show unilateral lesion and 11%
cases show bilateral lesions. Prakash et al found similar observation in his
study with 90.9% unilateral & 9.2% bilateral lesions [4], Gurung P et al [5] with
88.15% unilateral & 11.85% bilateral lesions, Prabhakar BR& Kalyani M [6]with
90.9% unilateral & 9.1% bilateral lesionsand by Couto F et al[7]having 91.2% unilateral ovarian
lesions & 8.7% bilateral lesions.So we can say that unilateral lesions are
more frequent than bilateral ones and all the studies show comparable outcomes[4,5,6,7].
Broad
categorization of these lesions includes Non-neoplastic cysts, BenignNeoplasms andBorderline-Malignant
Neoplasms. Our present study shows 44% cases of Non-neoplastic Cysts. Similar
studies like those done by Prakash A et al [4] and by Gurung P et al [5] shows
44.10% cases and 43.70% cases of Non-neoplastic Cysts respectively.In the study
done by Zaman et al[8], 68.87% of the lesions are non –neoplastic in nature
that is somewhat higher than other studies. Among all non-neoplastic cystic
enlargements, Simple Follicular Cyst, unilateral or bilateral is the commonest
one followed by Corpus Leuteal Cyst. Both of them are frequently seen among
women of reproductive age and perimenopausal age. Our present study shows 20%
of Follicular Cysts & 14% of Corpus Leuteal Cysts respectively. Study done
by Prakash A et al [4] shows 20.1% of Follicular Cysts & 10.9% of Corpus Leuteal
Cysts respectively. Gurung P et al [5]reported 17.0% of Endometriotic or
Chocolate cyst, 10.4 % of Simple Follicular Cyst and 9.6 % of Corpus Leuteal
Cyst and this result or outcome is not comparable with that of our present
study.
Our
present study shows 52% cases of benign neoplasms as well as 4% cases of
borderline & malignant neoplasms. Study done by Prakash A et al [4] shows
54.14% cases of benign neoplasms as well as 1.74% cases of borderline &
malignant neoplasms. Among benign neoplasms, Serous Cystadenoma is the
commonest one followed by Mature Cystic Teratoma (Dermoid Cyst) or Mucinous
Cystadenoma. Our present study shows 28% cases of Serous Cystadenoma, 13% cases
of Mature Cystic Teratoma and 6% cases of Mucinous Cystadenoma respectively. Yogambal
M et al[9] has reported 21.4% cases of Serous Cystadenoma and 19.9% cases of
Mature Cystic Teratoma. Pudasaini S et al[10] has reported 40.2% cases of
Serous Cystadenoma, 15.7% cases of Mature Cystic Teratoma and 9.8% cases of
Mucinous Cystadenoma. Maliheh
et al[11] has reported 38% cases of Serous
Cystadenoma, 30% cases of Mature Cystic Teratoma and 22% cases of Mucinous
Cystadenoma. Mondal et al [12]
has reported 29.9% cases of Serous Cystadenoma, 15.9% cases of Mature
Cystic Teratoma and 11.1% cases of mucinous cystadenoma. Iqbal et al [13] has reported 38.5% cases of Serous
Cystadenoma followed by 30.8% cases of Mature
Cystic Teratoma. Yasmin et al [14]
has reported 24% cases of Serous
Cystadenoma followed by 18% cases of Mature Cystic
Teratoma. Sowe can say that outcome of all these similar studies are comparable
with that of our present study.
In
our study, majority of the patients (58%) belong to age group of 20-39 years
followed by age group of 40-59 years (32%) and 60 years or more (10%). In our
study we have not included patients who are below 20 years of age. Comparison
of this age distribution with that of other similar studies is mentioned below
in table no. 3.
Table No.-3:Comparison of Age Distribution
of patients with ovarian lesions
Name of the Study |
Age Groups in Years |
|||
0-19 |
20-39 |
40-59 |
60 & above |
|
Ramachandran et al [15] |
7.9% |
53% |
30% |
9.1% |
Pilli et al [16] |
7% |
58% |
30% |
5% |
Kar et al [17] |
7.4% |
41.7% |
46.2% |
4.4% |
Prakash A et al [4] |
5.7% |
53.4% |
36.6% |
4.3% |
Present Study |
---- |
58% |
32% |
10% |
So
we can say that results of our present study are in concordance with that of
other similar studies. Ovarian lesions particularly non-neoplastic cysts &
benign neoplasms are commonly seen in age group of 20-39 years of age.
Our
present study includes four cases of borderline and malignant lesions. All of
them are Unilateral and show different age wise incidences. Borderline Mucinous
Tumor is seen at the age of 48 years. Prakash A et al [4] has also reported one
case of Borderline Mucinous Tumor with age of 35 years. We have reported one
case of Papillary Serous Cystadenocarcinoma in 65 years old female patient. Prakash
A et al [4] has also reported one similar case with age of 56 years. Gurung P
et al [5] has reported five such cases with age range of 38 to 66 years. Our
present study includes one case of Dysgerminoma of Ovary with age of 32 years.
Modi D et al [2] has reported one case of Dysgerminoma with age less than 20
years. Our present study also includes one case of Adult type Granulosa Cell
Tumor who is 45 years old. Modi D et al [2] has reported three such cases out
of which, two belongs to age group of 31-40 years and one belongs to age group of
41-50 years. Hatwal D et al [18] has reported one case of Granulosa Cell Tumor
of Adult type who is 45 years old. So we can say that age wise incidence of
Borderline & Malignant Neoplasms of our present study also correlate with
that of other similar studies. Dysgerminoma is a malignant neoplasm of younger
females while Borderline tumors and Granulosa cell tumor of Adult type are
commonly seen during middle age or perimenopausal age. Serous
Cystadenocarcinoma occurs at comparatively older age, usually beyond 60 years.
Conclusion
Ovarian
Lesions or Enlargements, both non-neoplastic and neoplastic include a variety
of morphological features and show a particular age wise incidence. Among
non-neoplastic lesions, simple follicular cyst is common while among benign
tumors, serous cystadenoma is common. Both are frequently bilateral. Malignant
Neoplasms of Ovary are rare as compared to Benign Neoplasms and Non-neoplastic
Lesions, but require a specific attention during diagnosis on both clinical and
pathological basis in order to save the patient’s life.
Role
of histopathological evaluation remains always
important in diagnosis and management of such cases along with clinical and
radiological evaluations. Histopathological study is useful to predict nature
and course of ovarian lesions so that future worse outcome can be prevented
with early intervention and marker study.
Contribution from authors
· Dr. Alpesh Maru: Data
collection, analysis and preparation of manuscript.
·
Dr.
Chirag Menpara: Analysis and preparation of manuscript
& critical revision.
Funding:Nil
Conflict of interest:None
Permission from IRB: Yes
References